Meet the Minnies finalists | Salary parity in radiology | More on gadolinium

Dear AuntMinnie Member,

Who made the final round in the Minnies, AuntMinnie.com's annual event recognizing excellence in radiology? The wait is over, as our expert panel has released its decisions.

The Minnies finalists range from Dr. Bruce Rosen, PhD, and Dr. Stephan Achenbach in the Most Influential Radiology Researcher category to Angelic McDonald and Charles Powell, PhD, in the Most Effective Radiology Administrator/Manager category. We also have competitions for Best Radiologist Training Program, Best New Radiology Device, Scientific Paper of the Year, and more.

Our expert panel will now pore over the finalists to determine the winners, with a decision expected later next month. Winners will receive handsome trophies, as well as the respect and adulation of their peers.

Can't wait until October? Then participate in our Best Radiology Image competition, underway right now on our Facebook Page. Two images were selected by our fans from among 11 scans that represent some of the most intriguing images produced in radiology over the past year. Click here to participate.

Salary parity in radiology

It's not unusual for radiology professionals to bemoan what's wrong with the discipline, but there appears to be at least one thing that it's doing right -- female radiologists enjoy salary parity with their male colleagues.

A new study of salaries at U.S. public medical schools found no statistically significant difference in salaries between male and female radiologists. The findings echo a previous study that found radiology was the only medical specialty to enjoy such salary equality.

Check out the findings -- and read a few theories on what radiology's doing right -- by clicking here, or visit our Imaging Leaders Community at leaders.auntminnie.com.

More on gadolinium

Finally, the controversy over gadolinium retention continues to churn. But this week we bring you news with a wrinkle: a study of a gadolinium-based contrast agent (GBCA) that found no retained gadolinium. A South Korean group found no signs of gadolinium deposition among nearly 400 patients who received a commercially available GBCA -- some of whom had 20 or more doses. Read more by clicking here, or visit our MRI Community at mri.auntminnie.com.

Page 1 of 611
Next Page